APA (7th ed.) Citation

Zafra‐Puerta, L., Iglesias‐Cabeza, N., Sciaccaluga, M., Bellingacci, L., Canonichesi, J., Sánchez‐Martín, G., . . . Serratosa, J. M. (2025). Advances in gene therapy for Lafora disease: Intravenous recombinant adeno‐associated virus‐mediated delivery of EPM2A and EPM2B genes. Clinical & Translational Medicine, 15(11), 1. https://doi.org/10.1002/ctm2.70514

Chicago Style (17th ed.) Citation

Zafra‐Puerta, Luis, Nerea Iglesias‐Cabeza, Miriam Sciaccaluga, Laura Bellingacci, Jacopo Canonichesi, Gema Sánchez‐Martín, Cinzia Costa, Marina P. Sánchez, and José M. Serratosa. "Advances in Gene Therapy for Lafora Disease: Intravenous Recombinant Adeno‐associated Virus‐mediated Delivery of EPM2A and EPM2B Genes." Clinical & Translational Medicine 15, no. 11 (2025): 1. https://doi.org/10.1002/ctm2.70514.

MLA (9th ed.) Citation

Zafra‐Puerta, Luis, et al. "Advances in Gene Therapy for Lafora Disease: Intravenous Recombinant Adeno‐associated Virus‐mediated Delivery of EPM2A and EPM2B Genes." Clinical & Translational Medicine, vol. 15, no. 11, 2025, p. 1, https://doi.org/10.1002/ctm2.70514.